🆕
thesicktimes.org
25/06/2026
FDA approves COVID-19 antiviral Xocova as PEP. But will it be accessible? - The Sick Times
Shionogi, the Japanese company that makes Xocova (ensitrelvir), said the post-exposure prophylaxis drug will be available in mid-July in the U.S. and will have a list price of $1,400. But its impact will hinge on how easily people can access it, expe